Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total assets
Total assets on the balance sheet as of December 2023 : $1.27 B
According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are $1.27 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.27 B | -24.95% |
| 2022-12-31 | $1.70 B | 0.79% |
| 2021-12-31 | $1.68 B | 12.3% |
| 2020-12-31 | $1.50 B | 29.63% |
| 2019-12-31 | $1.16 B | 18.66% |
| 2018-12-31 | $0.97 B | 130.36% |
| 2017-12-31 | $0.42 B | 37.11% |
| 2016-12-31 | $0.30 B | 64.12% |
| 2015-12-31 | $0.18 B | 37.9% |
| 2014-12-31 | $0.13 B | 23.23% |
| 2013-12-31 | $0.11 B | 18.09% |
| 2012-12-31 | $93.98 M | 74.93% |
| 2011-12-31 | $53.73 M | 14.3% |
| 2010-12-31 | $47 M | -41.16% |
| 2009-12-31 | $79.89 M | 3.59% |
| 2008-12-31 | $77.13 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 13,014.34% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 5,630.27% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 4,909.61% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 7,650.91% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 United Therapeutics UTHR | $7.16 B | 460.94% | 🇺🇸 USA |